Editorial
Inflammatory role of platelets in acute coronary syndromes
| The first 150 words of the full text of this article appear below. |
Increasing
evidence shows that inflammatory mediators play a pathogenic role in
atherogenesis and acute coronary syndrome.1 In particular,
several reports suggest that inflammatory cytokines such as tumour
necrosis factor
(TNF
), interleukin (IL)-1 and various chemokines
(for example, IL-8) may enhance degradation of the connective tissue
matrix protein by activating matrix metalloproteinases (MMPs) and
induce apoptosis of cells within the atherosclerotic lesion, promoting
plaque destabilisation and rupture.1 2 These findings
indicate a pathogenic link between persistent immune activation and
plaque rupture in coronary artery disease. It is well established that
platelets also contribute to the pathogenesis of acute coronary
syndromes by promoting thrombus formation. However, recent studies
suggest that these cells also may trigger an acute coronary event
through other mechanisms, such as stimulation of an inflammatory
response within the atherosclerotic plaque.
Several lines of evidence support a role for platelets as
inflammatory cells. Firstly, platelets provide
This article has been cited by other articles:
-
Iijima, R, Byrne, R A, Ndrepepa, G, Braun, S, Mehilli, J, Berger, P B, Schomig, A, Kastrati, A
(2009). Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials. Heart
95: 107-112
[Abstract] [Full Text] -
O'Kennedy, N., Crosbie, L., Whelan, S., Luther, V., Horgan, G., Broom, J. I, Webb, D. J, Duttaroy, A. K
(2006). Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans.. Am. J. Clin. Nutr.
84: 561-569
[Abstract] [Full Text] -
Otterdal, K., Smith, C., Oie, E., Pedersen, T. M., Yndestad, A., Stang, E., Endresen, K., Solum, N. O., Aukrust, P., Damas, J. K.
(2006). Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood
108: 928-935
[Abstract] [Full Text] -
Chakrabarti, S., Varghese, S., Vitseva, O., Tanriverdi, K., Freedman, J. E.
(2005). CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates. Arterioscler. Thromb. Vasc. Bio.
25: 2428-2434
[Abstract] [Full Text] -
Aukrust, P., Damas, J. K., Solum, N. O.
(2004). Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?. J Am Coll Cardiol
43: 2326-2328
[Full Text] -
Nannizzi-Alaimo, L., Alves, V. L., Phillips, D. R.
(2003). Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation. Circulation
107: 1123-1128
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
